ADVIA CENTAUR
Report
- Report Number
- 1219913-2026-00079
- Event Type
- Malfunction
- Date Received
- April 15, 2026
- Date of Event
- April 10, 2026
- Report Date
- May 15, 2026
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Product Code
- SEI
- UDI-DI
- 000630414591407
- PMA / PMN Number
- P100039
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
A CUSTOMER FROM OUTSIDE THE UNITED STATES REPORTED OBSERVATION OF FALSE REACTIVE (POSITIVE) ADVIA CENTAUR ANTI-HBS2 (AHBS2) RESULT FOR ONE PATIENT SAMPLE WHEN USING LOT 174 WHICH WAS DISCORDANT RELATIVE TO REPEAT TESTING USING DIFFERENT REAGENT LOT 176. SIEMENS IS EVALUATING THE EVENT.
THE CUSTOMER REPORTS OBSERVATION OF FALSE REACTIVE (POSITIVE) ADVIA CENTAUR ANTI-HBS2 (AHBS2) RESULT FOR ONE PATIENT SAMPLE WHEN USING LOT 174 WHICH WAS DISCORDANT RELATIVE TO REPEAT TESTING USING DIFFERENT REAGENT LOT 176. THE INITIAL REACTIVE RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). THE SAMPLE WAS REPROCESSED ON THE ORIGINAL ANALYZER WITH SAME REAGENT LOT, AGAIN YIELDING A REACTIVE RESULT. THE SAME SAMPLE WAS THEN REPROCESSED TWICE ON AN ALTERNATE ADVIA CENTAUR XP ANALYZER USING ANOTHER REAGENT LOT, AND BOTH RUNS PRODUCED NON-REACTIVE RESULTS. THE NONREACTIVE RESULTS WERE CONSIDERED CORRECT, AS THEY WERE IN AGREEMENT WITH THE PATIENT'S CLINICAL PICTURE. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSE REACTIVE AHBS2 RESULT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 158827 | ADVIA CENTAUR | ADVIA CENTAUR ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2) | SEI | SIEMENS HEALTHCARE DIAGNOSTICS INC. | N/A | 41082174 | 000630414591407 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Female |